Apyx Medical Shares Surge on Strong Quarterly Results

Financial Metrics Demonstrate Robust Improvement

Apyx Medical Corporation is experiencing a substantial upward movement in its share price following the release of impressive quarterly earnings. The medical technology specialist surpassed market expectations and achieved a dramatic reduction in its operational losses. Investors are responding enthusiastically to these positive developments, fueling significant gains.

The company’s latest financial report reveals substantial progress across key performance indicators:

• Revenue Growth: Increased by 12.1% to $12.9 million
• Loss Reduction: Narrowed from $4.7 million to $2.0 million
• EBITDA Improvement: Losses decreased by 96%
• Gross Margin: Expanded to 64.4%